REaCT-5G: a randomized trial of bone pain with 5-day-filgrastim vs. pegfilgrastim for neutropenia in breast cancer
Parvaneh Fallah, Jennifer Shamess, Carol Stober, Moira Rushton et al.
Citations
1 citations
Journal
JNCI Cancer Spectrum
Topics
Neutropenia and Cancer Infections
Field-Weighted Citation Impact (FWCI)
1.05
article
REaCT-5G: a randomized trial of bone pain with 5-day-filgrastim vs. pegfilgrastim for neutropenia in breast cancer
Parvaneh Fallah, Jennifer Shamess, Carol Stober, Moira Rushton, Mark Clemons, Fiona MacDonald, Natalie Mills, Terry L. Ng, Lisa Vandermeer, Kelly Daigle, Arif Awan, Monica Taljaard, Marie-France Savard, Sandeep R. Sehdev, Mohammed Ibrahim, Nasser Alqahtani, Stuart G. Nicholls, Daniel Davoudpour, John Hilton, Xinni Song, Peter Greenstreet
article en
1 citations
Abstract
No abstract available for this paper.
Publication Tag
JNCI Cancer SpectrumVol. 9(5)
Institutions
University of Ottawa (CA), Thunder Bay Regional Health Sciences Centre (CA), Ottawa Hospital (CA), King Abdulaziz Hospital (SA), St. Joseph Medical Center (US), Ottawa Hospital Research Institute (CA), McGill University (CA), NOSM University (CA), Champlain Regional College (CA)
Funders
Eli Lilly and Company, Pfizer, AstraZeneca, Gilead Sciences, Cancer Care Ontario, Incyte, Seagen, Astellas Pharma, Ontario Medical Association, EMD Serono